The role of Ins(1,4,5)P3 in the mobilization of Ca2+ from intracellular stores of non-muscle cells has been extensively demonstrated; however, the nature of the organelle releasing the Ca2+ is still poorly understood. The distributions of the Ins(1,4,5)PJ-binding sites and of the Ins(1,4,5)P3-sensitive Ca2+ pool were investigated in subcellular fractions obtained from rat liver and compared with those of other markers. The Ins(1,4,5)P3-binding vesicles appeared to be completely distinct from the endoplasmic-reticulum-derived microsomes and were enriched in the same fractions which were enriched in alkaline phosphodiesterase I activity. This co-purification of the plasma-membrane marker with the Ins(1,4,5)P3-binding sites was dramatically altered after freezing or after treatment of the homogenate with the microfilamentdisruptive drug cytochalasin B, suggesting that the Ins(1,4,5)P3-sensitive organelle may be linked to the plasma membrane through the actin microfilaments. No correlation was observed between the Ins(1,4,5)P3-binding capacity and the portion of the Ca2+ pool that was released by Ins(1,4,5)P3. This may result from the disruption of the native organelle during homogenization, leading to the formation of vesicles containing the Ins(1,4,5)P3 receptor, but lacking the Ca2+ pump. These results are consistent with the idea of a specialized Ins(1,4,5)P3-regulated organelle distinct from the endoplasmic reticulum, and we propose a model of the structural organization of this organelle, in which the anchorage to the cytoskeleton as well as the spatial separation of the Ca2+ pump from the Ins(1,4,5)P3 receptor have important functional significance.
INTRODUCTION
The role of Ins(1,4,5)P3 as mediator of intracellular Ca2+ mobilization in response to various extracellular stimuli is now well established, and has been extensively documented in permeabilized cells and microsomal preparations (for a review, see Berridge, 1987) . According to the current models, Ins(1,4,5)P3 acts through specific intracellular receptors; indeed, high-affinity binding sites for Ins(1,4,5)P3 have been described in various tissues (Baukal et al., 1985; Hirata et al., 1985; Spat et al., 1986a Spat et al., ,b, 1987 Worley et al., 1987a; Willcocks et al., 1987) . The purification and characterization of a 260 kDa Ins(1,4,5)P3-binding protein from rat cerebellum (Supattapone et al., 1988) and its functional reconstitution in lipid vesicles (Ferris et al., 1989) have previously been reported. A protein of similar size appears to be responsible for the high-affinity binding of Ins-(1,4,5)PJ observed in liver , and more recently have demonstrated that this liver Ins-(1,4,5)P3-binding site is the Ca2+-mobilizing receptor.
However, the nature and the location of the Ins(1,4,5)P3-sensitive Ca2+ pool are still controversial. The use of specific inhibitors of mitochondrial function have unequivocally excluded the mitochondria as the site of Ins(1,4,5)P3-induced Ca2l release (Berridge, 1987; Carafoli, 1987) , but at least two non-mitochondrial organelles have been proposed to fulfil this function in non-muscle cells: the endoplasmic reticulum and a newly described organelle, the calciosome . A role for endoplasmic reticulum was primarily supported by early subcellular fractionation of exocrine pancreas (Bayerd6rffer et al., 1984) , a tissue where this organelle is particularly abundant, and more recently by immunocytochemical labelling of the Ins-(1,4,5)P3 receptor in cerebellar Purkinje neurons (Ross et al., 1989) . However, the identity of the organelle sensitive to Ins-(1,4,5)P3 as endoplasmic reticulum has been strongly challenged, on the basis of results obtained from subcellular-fractionation studies of human neutrophils (Krause & Lew, 1987) , rat liver (Guillemette et al., 1988) , bovine adrenal cortex (Rossier et al., 1989) and dog brain (Alderson & Volpe, 1989) . The concept of an organelle distinct from the endoplasmic reticulum, and specifically involved in the control of [Ca2+] i by Ins(1,4,5)P3 in non-muscle cells, was suggested by morphological studies of HL60 and PC12 cells . This organelle, named the calciosome, was mainly characterized by its content of a calsequestrin-like protein . However, the presence of the Ins(1,4,5)P3 receptor on this organelle has not been demonstrated, and the presence of a calsequestrin-like protein in rat liver is still controversial (Damiani et al., 1988; Van et al., 1989) .
In this paper, we present evidence that the Ins(1,4,5)P3 receptors in rat liver are not located on the endoplasmic reticulum, and we show that the vesicles containing the Ins(1,4,5)P3-binding sites are enriched in parallel with the plasma-membrane marker during subcellular fractionation. This correlation is possibly due to actin microfilaments linking the Ins(1,4,5)P3-binding organelle to the peripheral membrane. We propose a model of the structural and functional organization of this organelle.
MATERIALS AND METHODS

Materials
Cytochalasin B, colchicine, heparin, BSA, EGTA, PMSF, dTMP p-nitrophenyl ester, cytochrome c, NADPH, Na2S2O4, Na2ATP, phosphocreatine, creatine kinase Livers from sodium pentobarbital-anaesthetized male Sprague-Dawley rats (200-350 g) were perfused in situ with 200 ml of Krebs-Ringer solution and fractionated by a modification of methods previously described for liver microsomes (Dawson, 1982) and plasma-membrane (Prpic et al., 1984) preparation. After removal, the liver was minced in a buffer containing 250 mM-sucrose, 5 mM-Hepes/KOH, 1 mM-EGTA and 1 mM-dithiothreitol, pH 7.4 (Buffer A), homogenized at 4°C with a glass Potter homogenizer (four strokes, 0.15 mm clearance), and then centrifuged for 10 min at 500 g. The pellet from this first centrifugation step (named 'HS' for high sedimentation coefficient) was resuspended in Buffer A at a concentration of 10-15 mg of protein/ml, supplemented with Percoll (14 %, v/v), and centrifuged for 30 min at 36000 g. Three distinct layers were obtained after formation of the density gradient: the top layer ('HSLD', of low density) contained flake-like structures floating in the medium, whereas both the intermediate ('HSMD', of medium density) and the bottom ('HSHD', of high density) layers appeared to be more compact. The latter fraction, HSHD, was contaminated with erythrocytes. The supernatant from the 500 g centrifugation step was centrifuged for 10 min at 2000 g to obtain a pellet with a medium sedimentation coefficient ('MS'), and the resulting supernatant was further centrifuged for 40 min at 36000 g to sediment the microsomes ('LS', of low sedimentation coefficient). Finally, the LS pellet was resuspended in Buffer A containing 35 % (v/v) Percoll and further fractionated by centrifugation at 36000 g for 30 min to produce low-density ('LSLD') and high-density ('LSHD') fractions. All the fractions obtained by centrifugation on Percoll gradients were washed in 10 vol. of a medium containing 120 mM-KCI and 20 mM-Hepes (pH 7.4). After a 40 min centrifugation at 36000 g, the membranes remaining above the hard Percoll pellet formed were removed and resuspended in 250 mM-sucrose/20 mM-Hepes buffer (pH 7.4) supplemented with 1 mM-dithiothreitol and 0.2 mM-PMSF. Samples of each fraction were stored at -20°C until assayed for various subcellular markers.
Assays for marker enzymes
All enzyme assays were carried out at 37 'C.
Alkaline phosphodiesterase I activity was used as a marker for plasma membrane, and determined by spectrometric assay of the dephosphorylation of dTMP p-nitrophenyl ester in a glycine buffer at pH 9.0 (Aronson & Touster, 1974) .
NADPH-dependent cytochrome c reductase activity was determined by colorimetric measurement of cytochrome c reduction in the presence of KCN and NADPH (Fleischer & Fleischer, 1967) . Sulphatase C activity was determined as previously described (Rossier et al., 1989) . Both activities were used as independent markers of the endoplasmic reticulum.
The mitochondrial cytochrome c oxidase activity (Wikstrom et al., 1981) was measured by colorimetric recording of cytochrome c oxidation after reduction of the substrate with Na2S204.
Protein concentration was measured by the Coomassie Blue method of Bradford (1976) , with BSA as standard.
13H1Ins(1,4,5)P3 binding
The specific Ins(1,4,5)PJ-binding capacity of the various subcellular fractions was determined by a modification of the method of Guillemette et al. (1987) . The membranes (0.5-1 mg of protein in 500 1u1) were incubated for 10 min at 4°C, in the presence of 50000 d.p.m. of [3H]Ins(1,4,5)P3 (approx. 1.5 nM), as previously described (Rossier et al., 1989) , except that the pH was adjusted to 8.4 instead of 7.4 unless otherwise specified. Non and supplemented with 1 ,ug of oligomycin/ml, 10 ,tM-antimycin, 1 mM-EGTA, 0.453 mM-CaCl2 (0.15 pM free Ca2+), and 1 /Ci of 45CaC12/ml. After a 5 min preincubation at 37°C, ATP-dependent 45Ca2+ uptake was initiated by addition of3 mM-Na2ATP and an ATP-regenerating system (10 mM-phosphocreatine and 8 units of creatine kinase/ml). The reaction was terminated after reaching the steady state (20 min) by filtration through GF/C glass-fibre filters pre-soaked in 230 mM-sucrose and 40 mM-NaCI (washing medium). The filters were rinsed with 2 x 4 ml of washing medium, dried, and the bound 45Ca2+ was measured by liquid-scintillation counting. The non-specific binding was estimated by omitting the ATP during the incubation, and the inhibitory effect of Ins(1,4,5)P3 on Ca2+ uptake was measured by adding 20 pM-Ins(1,4,5)P3 either immediately before ATP or 30 s before the end of the incubation.
RESULTS
Distribution of markers among the various subceliular fractions Freshly removed rat livers were homogenized and fractionated by differential centrifugation and by centrifugation on Percoll density gradients as described in the Materials and methods section. The specific activities of selected markers were measured in these fractions and expressed as a percentage of the activity present in the homogenate (H). Fig. l(b) shows the distribution of the alkaline phosphodiesterase I, a marker for the plasma membrane, the NADPH-dependent cytochrome c reductase, specific for the endoplasmic reticulum, and the cytochrome c oxidase, which is associated with the mitochondria. As expected, the marker for the endoplasmic reticulum, which is mostly disrupted into microsomes during the homogenization, is increased in fractions of lower sedimentation coefficient (LS and LSLD), whereas the marker for mitochondria is increased in fractions of higher sedimentation coefficient, characteristic of heavier and denser organelles (MS and HSHD). The fact that the alkaline phosphodiesterase I is enriched in both the heaviest (HSLD; 30 % recovery) and lightest (LSLD; 7 % recovery) fractions suggests that the plasma membrane is present in the form of large membrane sheets as well as smaller vesicles.
The specific [3H]Ins(1,4,5)P3 binding capacity of the various fractions was also determined (Fig. la) . This revealed a 5.6-fold enrichment of the binding sites in the HSLD fraction (450% recovery), whereas the microsomal fraction (LSLD) showed only a 2.2-fold increase in its capacity to bind [ (Worley et al., 1987b) , decreased the amount of bound tracer by 75 %. Because Ins(l,4,5)P3-binding sites did not co-purify with the NADPH-dependent cytochrome c reductase activity (Fig. 2b) , another marker of the endoplasmic reticulum, the sulphatase C activity, was also determined in the same fractions. We found a strong correlation (r = 0.949 for n = 10, P < 0.0001) between the distribution of both endoplasmic-reticulum markers, with a slope of almost 1 when the activities were expressed as percentage of homogenate activity (results not shown). This confirms the specificity of these markers for the endoplasmic reticulum and demonstrates that the Ins(1,4,5)P3-binding sites are distinct from this organelle.
Co-purification of the Ins(1,4,5)P3-binding sites with the plasma membrane
In contrast with what has been observed for the endoplasmicreticulum markers, the alkaline phosphodiesterase activity appeared to be enriched in the same fractions which showed an increase in the [3H]Ins(l,4,5)P3-binding capacity. Moreover, a significant correlation between the distribution of the Ins-(1,4,5)P3-binding sites and the plasma-membrane marker was reproducibly obtained when the fractions were prepared as described in the Materials and methods section (Fig. 2a) Table 2 . Effect of various treatments on the correlation between the Ins(1,4,5)P3-binding sites and the plasma membrane
The homogenates from five independent preparations (I-V) were divided, mixed 1: 1 (v/v) with a buffer containing 100 mM-KCI, 10 mM-MgCl2, 25 mM-Hepes, 1 mM-dithiothreitol, 20 #LM-PMSF, 0.5 mM-EGTA and 0.8 mM-CaC12, at pH 7.6, and incubated for 60 min at 37°C with 57 units of DNAase/ul, 1 #M-cytochalasin B (CB), or 2 ,M-colchicine (CC). Control homogenates were incubated without added agent, and in one experiment a part of the homogenate was frozen (at -80°C) and thawed (at + 20°C) three times before being incubated as the control. The membranes were then fractionated in parallel, and the markers determined in each fraction. The correlation between the Ins(1,4,5)P3-binding capacity and the plasma-membrane marker activity was analysed in each case as in Fig. 2 , and the r values, with their significance (*P < 0.05, **P < 0.01), were determined: n.d. means that the effect of a particular treatment was not determined in a particular experiment. Fig. 3(a) shows that cytochalasin B induced substantial changes in the distribution of the Ins(1,4,5)P3-binding sites. In contrast, cytochalasin B treatment did not modify the distribution of the alkaline phosphodiesterase I activity (Fig. 3b) . This effect on Ins(1,4,5)P3-receptor distribution cannot be explained by the variability within the assay. Indeed, when the distribution of Ins(1,4,5)P3-binding sites was compared in independent control preparations, the data were highly significantly correlated (r= 0.887, P < 0.005). .7) 55.4 (± 1.9) 
DISCUSSION
The most important finding of this study is that during subcellular fractionation of liver the Ins(1,4,5)P3-binding vesicles appear to be associated with the plasma membrane, and that this association is altered by freezing or treatment with the microfilament-disruptive drug cytochalasin B.
The fraction characterized by sedimentation at low-speed centrifugation and low density (HSLD) showed the highest Ins(1,4,5)P3-binding capacity (Fig. 1) . The characteristics of [3H]Ins(1,4,5)P3 binding in this fraction (Table 1) were consistent with those observed in microsomes from liver and other tissues; the binding was pH-dependent (Worley et al., 1987b; Rossier et al., 1989) and inhibited by heparin (Worley et al., 1987b; Hill et al., 1987; Kobayashi et al., 1988; Ghosh et al., 1988; Guillemette et al., 1989; Tones et al., 1989) .
By analysis of the distribution of the other markers, it appeared that the HSLD fraction was enriched in plasma membrane, whereas its content of endoplasmic reticulum was lower than that of the homogenate, and mitochondria were almost completely absent (Fig. 1) . These observations are consistent with the finding by Guillemette et al. (1988) that the fraction enriched in plasma membrane showed higher Ins(1,4,5)P3-binding capacity than those enriched in endoplasmic reticulum or mitochondria.
In addition, the lack of correlation between the Ins(l,4,5)P3-binding capacity and the content of endoplasmic reticulum, measured by either the NADPH-dependent cytochrome c reductase or the sulphatase C activity, strongly suggests that the Ins(l.,4,5)P3 receptors in liver are not located on the endoplasmicreticulum membrane. This result agrees with those obtained in neutrophils (Krause & Lew, 1987) , parotid cells (Henne et al., 1987) , adrenal cortex (Rossier et al., 1989 ) and brain (Alderson & Volpe, 1989) , but is in contradiction with early studies performed in pancreatic (Bayerdorffer et al., 1984) and insulinoma cells (Prentki et al., 1984) . It is not clear if this discrepancy is due to tissue specificity or to different fractionation protocols, because generally only the microsomal fractions have been analysed. Moreover, immunocytochemical detection of the Ins-(1,4,5)P3 receptor on the rough and smooth endoplasmic reticulum of neuronal cells (Ross et al., 1989) , a tissue where this protein is particularly abundant, may indicate newly synthesized receptor. It is noteworthy that the immunoreactive staining was also present in other structures, such as the cis cisternae of the Golgi apparatus, the nuclear membrane, and sub-plasmalemmal cisternae.
In rat liver, we have shown that the Ins(1,4,5)P^-binding sites are distinct from the endoplasmic reticulum. However, demonstration of the presence of a calsequestrin-like protein associated with the Ins(1,4,5)P3-receptor-containing vesicles will be necessary before concluding that this organelle is identical with the calciosomes previously described in HL60 and PC12 cells . Our results suggest that the Ins(1,4,5)P3-sensitive organelle in rat liver is divided into two functionally distinct regions, one being involved in Ca2" uptake and the other in Ca2" release. Another important feature is the anchorage of this organelle to the plasma membrane (PM) through actin microfilaments, which is suggested from the effect of cytochalasin B on the recovery of the Ins(1,4,5)P3-binding sites with plasma-membrane markers after homogenization. See the Discussion section for more details.
fractions (Fig. 2) . The possibility that a small portion of the alkaline phosphatase activity is present on the Ins(1,4,5)P3-sensitive organelle cannot be ruled out, but we are confident that the Ins(1,4,5)P3 receptor is not located on the plasma membrane. Indeed, freezing of the homogenate or treatment with cytoskeleton-disruptive drugs dramatically decreased this correlation (Table 2 ). In addition, fractionation of microsomes (but not of the HSLD fraction) on a high-resolution Percoll density gradient led to a partial separation between the Ins(1,4,5)P3-binding sites and the plasma-membrane marker (results not shown), suggesting that these organelles are less tightly bound in the microsomal fraction. A similar separation has been previously obtained with HL60-cell and adrenal cortex (Rossier et al., 1989) microsomes. Freezing and cytochalasin B treatment, perhaps by a common mechanism, resulted in two different effects:
(1) a redistribution of the Ins(l,4,5)P3-binding sites, decreasing their correlation with the plasma membrane, and (2) a significant increase in the Ins(1,4,5)P3-binding capacity of the various fractions. Both effects support the idea that the Ins(l,4,5)P3-binding organelle is associated with actin microfilaments. Interactions between the microfilament network and various intracellular organelles have been described previously; for example, actin has been found in association with isolated secretory granules (Jockusch et al., 1977) , and has been shown to induce cross-linking between lysosomal membranes (Mehrabian et al., 1984) . Microfilaments also appear to link the mitochondria to the endoplasmic reticulum in some steroidogenic cells (Aguas, 1981) . More recently, translocation of isolated organelles along actin filaments could be directly observed and the mechanism for this movement elucidated (Adams & Pollard, 1986 ).
Colchicine, although less effective than cytochalasin B, also caused a dissociation of the Ins(l,4,5)PJ-binding sites from the plasma membrane. It is less likely that microtubules are similarly bound to this organelle, because the effect of both drugs does not seem to be additive, but rupture of the microtubules, which can run closely in parallel to the microfilaments (Koonce & Schliwa, 1986) , may be responsible for a destabilization of the F-actin. If actin molecules are able to bind to the surface of the organelle in a specific way, we may hypothesize the presence of anchorage sites such as those present in the plasma membrane. The dramatic effect of cytochalasin B treatment on the Ins-(1,4,5)P3-binding capacity of the vesicles (Table 3) suggests that these sites may be close to, or associated with, the Ins(1,4,5)P3 receptor. This hypothesis is supported by the communication by Guillemette et al. (1990) that the Ins(1,4,5)P3 receptors in adrenal cortex and liver are partly resistant to solubilization with Triton X-100.
The microfilaments may provide a physical framework to maintain the Ins(1,4,5)P3-sensitive organelles at specific intracellular loci. The location of Ins(1,4,5)P3-sensitive Ca2+ pools near the plasma membrane, reminiscent of the morphology of the junctional sarcoplasmic reticulum in the smooth muscle (Somlyo, 1985) , is suggested by some current models relating intracellular Ca2+ release to plasma-membrane permeability (Putney, 1986; Mullaney et al., 1987; Takemura et al., 1989; Irvine, 1990) . In addition, several experimental observations support a close association between the plasma membrane and the Ins(1,4,5)P3-sensitive organelle; (1) serial Ins(1,4,5)P3 injections in Limulus photoreceptor cells (Payne & Fein, 1987) and immature Xenopus oocytes (Busa et al., 1985; Berridge, 1988) produce different responses, depending on the position of the micropipette within the cell; (2) following lysis and sonication of pancreatic islet cells attached to positively charged Sephadex beads, a significant part of the Ins(1,4,5)P3-sensitive Ca2+ pool remains associated with the beads (Dunlop & Larkins, 1988) ; (3) permeabilization of hepatocytes with saponin releases part of the Ins(1,4,5)P3-sensitive structures into the medium (Champeil et al., 1989) ; (4) muscarinic stimulation of parotid acinar cells induces opening of Ca2+-sensitive K+ channels before fura-2-detectable [Ca2+]i begins to rise (Foskett et al., 1989) ; and (5) immunocytochemical localization of the Ins(1,4,5)P3 receptor in Purkinje cells has revealed the presence of this protein, at least in part, in structures just beneath the plasma membrane (Ross et al., 1989) . Because this evidence is largely indirect, it is hoped that high-resolution spatial imaging of the intracellular Ca2+ pools will soon provide more reliable information concerning the intracellular location of this important organelle.
The ability of Ins(1,4,5)P3 to prevent 45Ca2+ accumulation into the vesicles, by maintaining a constant efflux of Ca2 , was measured in some fractions (Table 4) . Two important observations have been drawn from these experiments: (1) only a small fraction of the Ca2+ pool is releasable by Ins(1,4,5)P3, and (2) there is no correlation between the amount of Ca2+ released by Ins(1,4,5)P3 and the capacity of the vesicles to bind this agent. On the basis of kinetic studies of 45Ca2+ efflux from permeabilized hepatocytes (Taylor & Putney, 1985) , it has been estimated that Ins(1,4,5)P3 could discharge up to 400% of the total ATPdependent 45Ca2+ pool. After homogenization of the tissue, the size of the Ins(1,4,5)P3-releasable pool was markedly decreased to less than 10 % (see H in Table 4 ). In this study, after fractionation of the homogenate, the MS fraction appeared to be the most sensitive to Ins(1,4,5)P3 with approx. 21 % of its accumulated Ca2+ mobilizable by this agent. This result is consistent with the observation by Dawson & Irvine (1984) that, in the absence of GTP, the 'crude mitochondrial' fraction is more sensitive to Ins(1,4,5)P3 than is the microsomal fraction.
These results, as well as the lack of correlation between the binding and the effect of Ins(1,4,5)P3, are consistent with the model of fragmentation of the Ins(1,4,5)P3-sensitive Ca2+ pool recently proposed by Dawson & Comerford (1989) . This model proposes that, as in the sarcoplasmic reticulum of skeletal muscle, the Ca2+-pumping sites (Ca/Mg-ATPases) and the Ca2+-release sites [Ins(l, 4, 5) (Fig. 4) proposed that the integrity of the microfilaments is necessary for the function of the Ins(1,4,5)P3-sensitive pool in parietal cells (Tsunoda, 1986) . It has also been suggested that a decrease in Ca2+ content of the Ins(1,4,5)P3-sensitive pool leads to activation of Ca2+ influx through an unknown signalling mechanism (Takemura et al., 1989) , and perhaps microfilaments could be involved in that mechanism. The cytoskeleton is also a dynamic structure continuously changing its organization, and is involved in cell motility. Transportation of the Ca2+ pools to various places in the cytosol would be a useful way to modulate intracellular response, especially if the distance between the Ins(1,4,5)P3
receptor and the plasma membrane, where Ins(1,4,5)P3 is produced and metalolized (Storey et al., 1984; Shears et al., 1988) , is critical in controlling the concentration of Ins(1,4,5)P3 reaching the receptor. In neutrophils, translocation of calsequestrinlike protein-containing vesicles during cell activation has been observed (Krause et al., 1989) . Finally, the accessibility of the Ins(1,4,5)P3 receptor to the ligand could be regulated by steric effects, owing to the proximity of the Ins(1,4,5)P3-binding site to the anchorage site for the actin filaments.
In conclusion, it is becoming increasingly apparent that Ca2+ signalling and cytoskeletal dynamics are closely interrelated. The effect of Ca2+ ions on the assembly and disruption of the cytoskeleton has been known for some time; in the future, perhaps the influence of the cytoskeleton state on Ca2+ signalling will come to be equally appreciated.
